FDA Warning Letter — Acrostak (Schweiz) AG

Case 668948 — FEI 3005086865

The FDA took a Warning Letter action against Acrostak (Schweiz) AG on October 31, 2023 (Winterthur, Switzerland). The action was issued by CDRH and concerns devices products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
Acrostak (Schweiz) AG
Date
October 31, 2023
Fiscal Year
2024
Product Type
Devices
Center
CDRH
Location
Winterthur (Switzerland)